Merck Sells Federally Financed Covid Pill to U.S. for 40 Times What It Costs to Make

October 6th, 2021

Seriously, y’all. Stop it.

Via: The Intercept:

A five-day course of molnupiravir, the new medicine being hailed as a “huge advance” in the treatment of Covid-19, costs $17.74 to produce, according to a report issued last week by drug pricing experts at the Harvard School of Public Health and King’s College Hospital in London. Merck is charging the U.S. government $712 for the same amount of medicine, or 40 times the price.

Leave a Reply

You must be logged in to post a comment.